What works for human papillomavirus vaccine introduction in low and middle-income countries?

by Howard, N, Gallagher, KE, Mounier-Jack, S, Burchett, HED, Kabakama, S, LaMontagne, DS, Watson-Jones, D
Published 2021

Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007–2016

by Gallagher, KE, Howard, N, Kabakama, S, Mounier-Jack, S, Burchett, HED, LaMontagne, DS, Watson-Jones, D
Published 2021

The value of demonstration projects for new interventions: The case of human papillomavirus vaccine introduction in low- and middle-income countries

by Howard, N, Mounier-Jack, S, Gallagher, KE, Kabakama, S, Griffiths, UK, Feletto, M, LaMontagne, DS, Burchett, HED, Watson-Jones, D
Published 2021

Lessons learnt from human papillomavirus (HPV) vaccination in 45 low-and middle income countries

by Gallagher, Katherine E, Howard, Natasha, Kabakama, Severin, Mounier-Jack, Sandra, Griffiths, Ulla K, Feletto, Marta, Burchett, Helen ED, LaMontagne, D Scott, Watson-Jones, Deborah
Published 2021

Social mobilisation, consent and acceptability: a review of human papillomavirus vaccination procedures in low and middle-income countries

by Kabakama, Severin, Gallagher, Katherine E, Howard, Natasha, Mounier-Jack, Sandra, Burchett, Helen ED, Griffiths, Ulla K, Feletto, Marta, LaMontagne, D Scott, Watson-Jones, Deborah
Published 2021